Why This Could Be the Most Exciting Time in Cancer Research History

This could be the most exciting time in cancer-research history; previously deadly diseases may be curable in some patients. But there’s a cost. Bloomberg Gadfly’s Max Nisen looks at why cancer medicines are at the center of the next big drug-pricing fight.


The Equedia Letter is Canada’s fastest growing and largest investment newsletter dedicated to revealing the truths about the stock market.